Email this article Assessment of in silico antioxidant, anti-inflammatory, and antidiabetic activites of ximenia Americana L. Olacaceae
Abstract
Persistent hyperglycemia leading to oxidative stress and inflammatory response contributes to the pathology of diabetes. This study investigated the antioxidant, anti-inflammatory, and antidiabetic potential of Ximenia americana (XA) L. Olacaceae in silico exploring its possible mechanism of action. The study was carried out by molecular docking of the compounds present in XA with the antioxidant, anti-inflammatory, and antidiabetic targets followed by molecular dynamics simulation. Stigmasterol exhibited the lowest respective binding affinity and inhibition constant with xanthine oxidases (-8.7 kcal/mol and 4.13 ×10-1 µM), cytochrome p450 21A2 (-11.5 kcal/mol and 3.64 × 10-3 µM), myeloperoxidase (-10 kcal/mol and 4.59 × 10-2 µM), phospholipase A2 (-9.3 kcal/mol and 1.50 × 10-1 µM), inducible nitric oxide synthase (-10.8 kcal/mol and 1.19 × 10-2 µM), 11β hydroxy-steroid dehydrogenase 1 (-9.4 kcal/mol and 1.27×10-1 µM), and alpha-amylase (-9.6 kcal/mol and 1.27×10-1 µM) while 4,4-Dimethylcyclohex-2-en-1-ol showed the least BA (-7.6 kcal/mol) and Ki (2.65 µM) with interleukin associated kinase 4. Furthermore, the molecular dynamics simulation shows high residue displacements of up to 6.11, 3.69, 4.97, 5.24, 4.21, 4.41, 5.80, and 5.76 Å for xanthine oxidase, cytochrome p450 21A2, myeloperoxidase, phospholipase A2, inducible nitric oxide synthase, interleukin associated kinase 4, alpha-amylase, and 11β hydroxy-steroid dehydrogenase 1, respectively. Conclusively, stigmasterol and 4,4-Dimethylcyclohex-2-en-1-ol might be the key compounds involved in the antioxidant, anti-inflammatory, and antidiabetic activity of XA via inhibition of the enzymes involved in oxidative stress, inflammation, and diabetes.
Received: 13 October 2023
Accepted: 20 February 2024
Published: 15 March 2024
Keywords
Full Text:
PDFReferences
Almeida C, Monteiro C, Silvestre S. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 as potential drugs for type 2 diabetes mellitus—a systematic review of clinical and in vivo preclinical studies. Vol. 89, Scientia Pharmaceutica. 2021.
Bakrim W Ben, Nurcahyanti ADR, Dmirieh M, Mahdi I, Elgamal AM, El Raey MA, et al. Phytochemical Profiling of the Leaf Extract of Ximenia americana var. caffra and Its Antioxidant, Antibacterial, and Antiaging Activities in Vitro and in Caenorhabditis elegans: A Cosmeceutical and Dermatological Approach. Oxid Med Cell Longev. 2022;2022.
Bhatti JS, Sehrawat A, Mishra J, Sidhu IS, Navik U, Khullar N, et al. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radic Biol Med. 2022 May;184:114–34.
Chalimoniuk M. [Secretory phospholipase A2 and its role in oxidative stress and inflammation]. Vol. 58, Postepy biochemii. 2012.
Chen S, Chen H, Du Q, Shen J. Targeting Myeloperoxidase (MPO) Mediated Oxidative Stress and Inflammation for Reducing Brain Ischemia Injury: Potential Application of Natural Compounds. Vol. 11, Frontiers in Physiology. 2020.
da Silva-Leite KES, Girão DKFB, de Freitas Pires A, Assreuy AMS, de Moraes PAF, Cunha AP, et al. Ximenia americana heteropolysaccharides ameliorate inflammation and visceral hypernociception in murine caerulein-induced acute pancreatitis: Involvement of CB2 receptors. Biomedicine & Pharmacotherapy. 2018 Oct;106:1317–24.
da Silva BAF, Pessoa RT, da Costa RHS, de Oliveira MRC, Ramos AGB, de Lima Silva MG, et al. Evaluation of the antiedematogenic and anti-inflammatory properties of Ximenia americana L. (Olacaceae) bark extract in experimental models of inflammation. Biomedicine & Pharmacotherapy. 2023 Oct;166:115249.
Dahiru MM. Recent advances in the therapeutic potential phytochemicals in managing diabetes. Journal of Clinical and Basic Research. 2023;7(1):13–20.
Mubarak Muhammad Dahiru, Enoch Buba Badgal, Neksumi Musa. Phytochemistry, GS-MS analysis, and heavy metals composition of aqueous and ethanol stem bark extracts of Ximenia americana. GSC Biological and Pharmaceutical Sciences. 2022;21(3).
Dahiru MM, MN, AAM, & AMA. Potential Antidiabetic Compounds from Anogeissus leiocarpus: Molecular Docking, Molecular Dynamic Simulation, and ADMET Studies. Borneo Journal of Pharmacy. 2023;6(3).
Dahiru M, Samuel N. A review of the mechanisms of action and side effects of anti-diabetic agents. Trends in Pharmaceutical Sciences [Internet]. 2022 Sep [cited 2024 Mar 4];8(3). Available from: https://doi.org/10.30476/tips.2022.95931.1153
De Nardo D, Balka KR, Cardona Gloria Y, Rao VR, Latz E, Masters SL. Interleukin-1 receptor–associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling. Journal of Biological Chemistry. 2018 Sep;293(39):15195–207.
Ellulu MS, Samouda H. Clinical and biological risk factors associated with inflammation in patients with type 2 diabetes mellitus. BMC Endocr Disord. 2022 Jan 6;22(1):16.
Ferenczy GG, Kellermayer M. Contribution of hydrophobic interactions to protein mechanical stability. Comput Struct Biotechnol J. 2022;20.
Gandhi Y, Kumar R, Grewal J, Rawat H, Mishra SK, Kumar V, et al. Advances in anti-inflammatory medicinal plants and phytochemicals in the management of arthritis: A comprehensive review. Food Chemistry Advances. 2022 Oct;1:100085.
Jendele L, Krivak R, Skoda P, Novotny M, Hoksza D. PrankWeb: a web server for ligand binding site prediction and visualization. Nucleic Acids Res. 2019 Jul 2;47(W1):W345–9.
Kaur N, Kumar V, Nayak SK, Wadhwa P, Kaur P, Sahu SK. Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review. Chem Biol Drug Des. 2021 Oct 4;98(4):539–60.
Kefelegn GA, Desta B. Ximenia americana: Economic Importance, Medicinal Value, and Current Status in Ethiopia. The Scientific World Journal. 2021 Mar 8;2021:1–7.
Korac B, Kalezic A, Pekovic-Vaughan V, Korac A, Jankovic A. Redox changes in obesity, metabolic syndrome, and diabetes. Redox Biol. 2021;42.
Kurcinski M, Oleniecki T, Ciemny MP, Kuriata A, Kolinski A, Kmiecik S. CABS-flex standalone: A simulation environment for fast modeling of protein flexibility. Bioinformatics. 2019;35(4).
López-Blanco JR, Aliaga JI, Quintana-Ortí ES, Chacón P. IMODS: Internal coordinates normal mode analysis server. Nucleic Acids Res. 2014;42(W1).
Nwozo OS, Effiong EM, Aja PM, Awuchi CG. Antioxidant, phytochemical, and therapeutic properties of medicinal plants: a review. Int J Food Prop. 2023 Sep 22;26(1):359–88.
Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11(3).
Ortiz CLD, Completo GC, Nacario RC, Nellas RB. Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies. Sci Rep. 2019 Nov 19;9(1):17096.
Pallan PS, Wang C, Lei L, Yoshimoto FK, Auchus RJ, Waterman MR, et al. Human cytochrome P450 21A2, the major steroid 21-hydroxylase: Structure of the enzyme•progesterone substrate complex and rate-limiting C-H bond cleavage. Journal of Biological Chemistry. 2015;290(21).
Papi S, Ahmadizar F, Hasanvand A. The role of nitric oxide in inflammation and oxidative stress. Immunopathologia Persa. 2019 Apr 13;5(1):e08–e08.
Przeor M. Some Common Medicinal Plants with Antidiabetic Activity, Known and Available in Europe (A Mini-Review). Vol. 15, Pharmaceuticals. 2022.
Sangwung P, Petersen KF, Shulman GI, Knowles JW. Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications. Endocrinology. 2020 Apr 1;161(4).
Sanner MF. Python: A programming language for software integration and development. Vol. 17, Journal of Molecular Graphics and Modelling. 1999.
Shettar AK, Kotresha K, Kaliwal BB, Vedamurthy AB. Evaluation of in vitro antioxidant and anti-inflammatory activities of Ximenia americana extracts. Asian Pac J Trop Dis. 2015 Nov;5(11):918–23.
Shettar AK, Sateesh MK, Kaliwal BB, Vedamurthy AB. In vitro antidiabetic activities and GC-MS phytochemical analysis of Ximenia americana extracts. South African Journal of Botany. 2017 Jul;111:202–11.
Shields HJ, Traa A, Van Raamsdonk JM. Beneficial and Detrimental Effects of Reactive Oxygen Species on Lifespan: A Comprehensive Review of Comparative and Experimental Studies. Vol. 9, Frontiers in Cell and Developmental Biology. 2021.
Singh A, Singh K, Sharma A, Kaur K, Chadha R, Singh Bedi PM. Past, present and future of xanthine oxidase inhibitors: design strategies, structural and pharmacological insights, patents and clinical trials. RSC Med Chem. 2023;14(11):2155–91.
Veith A, Moorthy B. Role of cytochrome P450s In the generation and metabolism of reactive oxygen species. Vol. 7, Current Opinion in Toxicology. 2018.
Wronka M, Krzemińska J, Młynarska E, Rysz J, Franczyk B. The Influence of Lifestyle and Treatment on Oxidative Stress and Inflammation in Diabetes. Vol. 23, International Journal of Molecular Sciences. 2022.
Yoshimoto FK, Zhou Y, Peng HM, Stidd D, Yoshimoto JA, Sharma KK, et al. Minor activities and transition state properties of the human steroid hydroxylases cytochromes P450c17 and P450c21, from reactions observed with deuterium-labeled substrates. Biochemistry. 2012;51(36).
Yousef H, Khandoker AH, Feng SF, Helf C, Jelinek HF. Inflammation, oxidative stress and mitochondrial dysfunction in the progression of type II diabetes mellitus with coexisting hypertension. Front Endocrinol (Lausanne). 2023;14.
Zhang P, Li T, Wu X, Nice EC, Huang C, Zhang Y. Oxidative stress and diabetes: antioxidative strategies. Vol. 14, Frontiers of Medicine. 2020.
DOI: http://dx.doi.org/10.21622/AMPDR.2024.04.1.735
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Mubarak Muhammad Dahiru, Mahmud Bala Alfa, Maimuna Abdulrahman Abubakar, Aliyu Pela Abdulllahi
Advances in Medical, Pharmaceutical and Dental Research
E-ISSN: 2812-4898
P-ISSN: 2812-488X
Published by:
Academy Publishing Center (APC)
Arab Academy for Science, Technology and Maritime Transport (AASTMT)
Alexandria, Egypt
ampdr@aast.edu
